Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT

NCT: NCT07711626 · RECRUITING

NCT IDNCT07711626
StatusRECRUITING
Start Date2026-07-13
Completion2028-12-31
SponsorTzu Chi University (OTHER)
First posted
Last updated

Brief Summary

Head and neck cancer (HNC) patients undergoing concurrent chemoradiotherapy (CCRT) frequently experience pain, xerostomia, fatigue, sleep disturbance, and other treatment-related toxicities that impair quality of life and treatment adherence, with incomplete relief from current supportive care. This randomized, single-blind, sham-controlled trial evaluates whether foot reflexology (FR), transcutaneous auricular vagus nerve stimulation (ta-VNS), and auricular acupressure (AA) reduce pain, xerostomia, fatigue, sleep disturbance, and treatment-related symptoms in HNC patients receiving cisplatin-based CCRT, compared with usual care. Participants are randomized to a foot reflexology group, an auricular vagus nerve stimulation group (each with true and sham subgroups), or a usual-care control group, and are followed at baseline and weeks 1, 2, and 4.

Frequently Asked Questions

What is Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT?

Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT is a clinical trial registered under NCT07711626. Current status: RECRUITING.

What is the status of NCT07711626?

The current status of NCT07711626 (Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT) is: RECRUITING.

When did Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT start?

Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT started on 2026-07-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.